Log In
Print
BCIQ
Print
Print this Print this
 

Adderall XR, dextroamphetamine/amphetamine

Also known as: MAS XR (SLI 381)

  Manage Alerts
Collapse Summary General Information
Company Shire plc
DescriptionExtended-release formulation of Adderall, mixed salts of a single entity amphetamine
Molecular Target Unknown
Mechanism of ActionUnknown
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationAttention deficit hyperactivity disorder (ADHD)
Indication DetailsTreat attention deficit hyperactivity disorder (ADHD); Treat attention deficit hyperactivity disorder (ADHD) in adults
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today